Patient
SITE008-0022
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE008 (KOR) (Dr. Kim)
consented 2025-09-12
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-23 (study day 334); relationship: NOT RELATED
Grade 2 Vomiting — outcome: RECOVERED/RESOLVED; onset 2023-01-06 (study day 286); relationship: not assessed
Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-09-16 (study day 174); relationship: not assessed
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-09-12 (study day 170); relationship: NOT RELATED
Grade 3 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-07-18 (study day 114); relationship: NOT RELATED
Grade 2 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-06-24 (study day 90); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.